Abstract
ABSTRACT. Using four different digoxin kits, it was disclosed that the majority of various samples including amniotic fluid, cord blood, and serum from neonates contained substantial levels of digoxin-like immunoreactive substance. The differences in data seemed to be due to the range of epitopes which are recognized by antidigoxin antiserum. The day-to-day studies on sera serially obtained from infants at birth to 48 days old revealed that the level of the substance (0.31 ± 0.12 ng/ml) in sera of the 1-dayold neonates rapidly declined to the level of 0.1 ng/ml by the 2nd postnatal wk and thereafter gradually declined. The immunological specificity and accuracy of the detection of digoxin-like immunoreactive substance was confirmed by a sample dilution test, a recovery test for standard digoxin, and an absorption test with antidigoxin antiserum. The amniotic fluid and cord blood also contained four to eight times more of a digitoxin-like immunoreactive substance than they did digoxin-like immunoreactive substance. A significant correlation was observed between the levels of digoxin-like immunoreactive substance and of digitoxin-like immunoreactive substance (p<0.01).
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ebara, H., Suzuki, S., Nagashima, K. et al. Digoxin- and Digitoxin-Like Immunoreactive Substances in Amniotic Fluid, Cord Blood, and Serum of Neonates. Pediatr Res 20, 28–31 (1986). https://doi.org/10.1203/00006450-198601000-00007
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-198601000-00007
This article is cited by
-
Endogenous factors with immunological and biological activity similar to cardiac glycosides: Biochemical and pathophysiological implications
Journal of Endocrinological Investigation (1992)
-
Digoxin-like immunoreactive substance in serum of preterm and full-term neonates
European Journal of Pediatrics (1987)